In 2013, Carl June, MD, won the Philadelphia Award for his pioneering work in the use of engineered chimeric antigen-modified T cells (so-called "killer" T Cells) to treat acute lymphoid leukemia and chronic lymphocytic leukemia.
Related Links
Published
August 14, 2014
Created by
BROADCASTMED